TekniPlex Healthcare coextruded barrier structures enable commercialization of emerging drug therapies

As the demand for liquid injectable therapies grows, pharmaceutical companies are seeking advanced packaging solutions to enhance patient care and drug efficacy. One such company faced challenges in finding the right high-barrier flexible film for its primary packaging, essential for maintaining drug stability for up to two years while minimizing moisture loss and providing robust protection against active pharmaceutical ingredients (APIs) and excipients. Traditional multilayer films often compromised safety and efficacy due to high levels of extractables and leachables from reactive adhesives used in lamination. The company needed a film supplier with multilayer coextrusion capabilities and a collaborative R&D team to develop a solution tailored to its specific requirements. TekniPlex Healthcare partnered with the pharmaceutical company to provide innovative film options that addressed their concerns.